Tag: National Institutes of Health

  • Crisis and Opportunity: Cassava Sciences Still a Strong Buy

    Crisis and Opportunity: Cassava Sciences Still a Strong Buy

    “With SAVA, once the pullback has exhausted itself, it’s a strong buy,” we noted on July 29. Since bottoming out around $65, the stock is back to $86.20 – and could refill its bearish gap around $140 with patience.  In fact, if the company can continue to progress with its Alzheimer’s treatment, this stock could…

  • Why Cassava Sciences Could be a Buy Again on Weakness

    Why Cassava Sciences Could be a Buy Again on Weakness

    On July 22, we mentioned Cassava Sciences was one of the hottest stocks on the market. In fact, since mentioning it, the stock ran from about $108 to $144.63. All thanks to a build-up of excitement ahead of its presentation at the 2021 Alzheimer’s Association International Conference.  Today, though, the stock is down about $11…